<DOC>
	<DOCNO>NCT00263055</DOCNO>
	<brief_summary>Safety &amp; tolerability FOLFOX4 regimen adjuvant treatment colon cancer Asian patient</brief_summary>
	<brief_title>MASCOT : Multicenter Asia Study Adjuvant Treatment Colon Cancer With OxaliplaTin/5FU-LV</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically proven stage Dukes `` B2 `` ( stage II : T3T4 N0 M0 ) `` C `` ( stage III : T N12 M0 ) colon carcinoma . The inferior pole tumor must peritoneal reflection ( &gt; 15 cm anal margin ) . Patients must undergo complete resection primary tumor without gross microscopic evidence residual disease Patients must enter study order start treatment within 7 week surgery Age 1875 year old Performance Status ≤ 2 ( Karnofsky &gt; = 60 % ) No previous chemotherapy , immunotherapy radiotherapy No biological major abnormality : Absolute neutrophil count &gt; 1.5 x 10^9/l , Platelets ≥ 100 x 10^9/l , Serum creatinine ≤ 1.25 time upper limit normal , total bilirubin , ASAT / ALAT &lt; 2 time upper limit normal range , carcinoembryonic antigen &lt; 10 ng/ml . Documentation negative pregnancy test must available premenopausal woman intact reproductive organ Men woman fertile must use medically acceptable contraceptive throughout treatment period 3 month follow cessation treatment oxaliplatin . Subjects must make aware , enter trial risk become pregnant fathering child Signed informed consent obtain prior study entry Exclusion criterion Pregnant lactate woman Women child bear potential use contraceptive method Previous cancer colon rectum Previous malignancy adequately treat situ carcinoma uterine cervix basal squamous cell carcinoma skin , unless diseasefree interval least 10 year Participation another clinical trial investigational drug within 30 day prior randomization Peripheral neuropathy ( NCI CTC [ National Cancer Institute Common Toxicity Criteria ] &gt; = Grade I ) Uncontrolled congestive heart failure angina pectoris , hypertension arrhythmia History significant neurologic psychiatric disorder Active infection The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>